Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and CymaBay Therapeutics, Inc. (CBAY)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and CBAY | ||
|---|---|---|
| S&P 500 | CBAY | |
| Start Date | Oct-01-2014 | Apr-30-2014 |
| Start Price | $2,543.70 | $7.99 |
| End Date | Oct-01-2024 | Apr-01-2024 |
| End Price | $5,708.75 | $32.48 |
| Number Monthly Prices | 121 | 121 |
| Min Date | Feb-01-2016 | Jan-29-2016 |
| Min Price | $2,503.97 | $1.09 |
| Max Date | Oct-01-2024 | Apr-01-2024 |
| Max Price | $5,708.75 | $32.48 |
| Total Return | 124.43% | 306.51% |
| Annualized Return | 8.35% | 14.92% |
| Current Value of $1,000 Purchase | $2,244 | $4,065 |
| Number Returns | 7,260 | 7,260 |
| Average Return | 31.14% | 134.72% |
| Minimum Return | -25.54% | -90.06% |
| Maximum Return | 127.99% | 2,879.82% |
| Number Profitable Returns | 6,521 | 4,231 |
| Percent Profitable Returns | 89.82% | 58.28% |
| Number Unprofitable Returns | 739 | 3,029 |
| Percent Unprofitable Returns | 10.18% | 41.72% |
| Profitable to Unprofitable Returns Ratio | 8.82 | 1.40 |
CBAY Performance Table and Chart
CBAY Dollar-cost Average
CBAY Trendline Chart
CBAY Moving Average Chart
CBAY Stock Return Map - See Patterns of Gains and Losses
CBAY Stock Returns/Purchase Dates